Greg Moeck
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 39
- Antibiotics Pharmacokinetics and Efficacy 39
-
- Antimicrobial Resistance in Staphylococcus 34
- Co-authors
- James W. Coulton (6 shared papers)Francis F. Arhin (37 shared papers)Adam Belley (20 shared papers)Thomas Parr (18 shared papers)Geoffrey A. McKay (13 shared papers)Ingrid Sarmiento (16 shared papers)Lucienne Letellìer (3 shared papers)Sylvain Beaulieu (6 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (26 papers)Open Forum Infectious Diseases (9 papers)International Journal of Antimicrobial Agents (8 papers)Journal of Bacteriology (5 papers)Diagnostic Microbiology and Infectious Disease (5 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Greg Moeck
74 papers receiving 2.6k citations
Greg Moeck's Hit Papers
Peers
Comparison fields: 5 of 106
- Molecular Medicine 687
- Applied Microbiology and Biotechnology 153
- Clinical Biochemistry 458
- Infectious Diseases 1.1k
- Microbiology 318
Countries citing papers authored by Greg Moeck
This map shows the geographic impact of Greg Moeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Moeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Moeck more than expected).
Fields of papers citing papers by Greg Moeck
This network shows the impact of papers produced by Greg Moeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Moeck. The network helps show where Greg Moeck may publish in the future.
Co-authors
The 25 scholars most cited alongside Greg Moeck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 243 | |
| 2 | 2014 | 226 | |
| 3 | 2004 | 175 | |
| 4 | 2014 | 169 | |
| 5 | 2008 | 142 | |
| 6 | 2009 | 114 | |
| 7 | 2010 | 96 | |
| 8 | 2008 | 92 | |
| 9 | 1997 | 84 | |
| 10 | 1996 | 74 | |
| 11 | 2008 | 72 | |
| 12 | Cefepime–Taniborbactam in Complicated Urinary Tract Infection Hit paper breakdown → | 2024 | 67 |
| 13 | 2008 | 65 | |
| 14 | 1999 | 60 | |
| 15 | 2001 | 58 | |
| 16 | 2009 | 51 | |
| 17 | 2015 | 48 | |
| 18 | 2010 | 48 | |
| 19 | 2022 | 45 | |
| 20 | 2005 | 45 |
About Greg Moeck
Greg Moeck is a scholar working on Pharmacology, Infectious Diseases, Molecular Medicine, Epidemiology and Clinical Biochemistry, having authored 78 papers that have together received 2.7k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (39 papers), Antimicrobial Resistance in Staphylococcus (34 papers), Antibiotic Resistance in Bacteria (33 papers), Bacterial Identification and Susceptibility Testing (16 papers), Bacterial Genetics and Biotechnology (12 papers), Antibiotic Use and Resistance (8 papers), Pneumonia and Respiratory Infections (7 papers) and Bacteriophages and microbial interactions (7 papers). The work is most often cited by research in Molecular Medicine (687 citations), Applied Microbiology and Biotechnology (153 citations), Clinical Biochemistry (458 citations), Infectious Diseases (1.1k citations) and Microbiology (318 citations). Greg Moeck has collaborated with scholars based in United States, Canada and France. Frequent co-authors include James W. Coulton, Francis F. Arhin, Adam Belley, Thomas Parr, Geoffrey A. McKay, Ingrid Sarmiento, Lucienne Letellìer, Sylvain Beaulieu, Daniel F. Sahm and Hai Jiang. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, International Journal of Antimicrobial Agents, Journal of Bacteriology and Diagnostic Microbiology and Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.